High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.
about
Adipokines, metabolic syndrome and rheumatic diseasesEmerging role of adipokines in systemic lupus erythematosus.Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico.Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Management of cardiovascular complications in systemic lupus erythematosus.Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors.Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupusSeropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.The role of adipokines in connective tissue diseases.Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study.Contemporary treatment of systemic lupus erythematosus: an update for clinicians.Risk factors in cardiovascular disease in systemic lupus erythematosus.Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications.Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial.Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosusNovel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.Psoriatic arthritis and diabetes: a population-based cross-sectional studyRelation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus.Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits.N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification.Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis.High Prevalence of Metabolic Syndrome in Patients with Discoid Lupus Erythematosus: A Cross-Sectional, Case-Control Study.Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome.Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians.SLE and metabolic syndrome.Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach.Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus?Update on cardiovascular disease in lupus.Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness.Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials.Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.
P2860
Q26865268-4EA483E5-16C2-4A34-A65E-16E727BA1C16Q30249547-3C394DB0-3745-4182-A91C-673A6320F9B5Q30560952-8EDDB70B-59E8-4046-8001-CE63F3537235Q30791606-85C14CAA-0CE4-4BF6-A7BB-547530AC7387Q30993000-102724C4-B064-47A1-9D77-1D41B690FBE1Q33379277-87D594E4-CFE7-4D0A-B8D9-48398EF81306Q33425745-6928E555-72D9-44A5-9BC5-DCB057110061Q33633643-533E6909-E616-43D4-83CA-C0F2DB9F9849Q33723511-204ECCC9-89BB-49C5-8B65-6FF3CFC18188Q33730536-C779852B-6D1A-400A-9C51-F31542803318Q34167222-351CB887-B5F9-496F-B35A-BCEA008FDA6AQ34343906-06CAF9E3-B05B-4C35-90A5-924146995DFDQ35840769-43FA93B6-6271-4E0B-A084-7B166B160AF2Q36095970-9C9646E2-4159-40F1-89A7-571E3540537BQ36359128-9A826FB3-2239-40C6-994B-A4C0A3874F8EQ36443689-2F95565B-AEC6-455A-9265-4DD172D686BAQ36644837-93B908F7-EE02-4AAC-A254-DBB9CA33E704Q36790316-58DA9387-3D07-4262-A8AE-AD8781E67730Q36903145-C6C51901-B580-45C9-9422-C46625F4EB4FQ36934234-028E35CC-C644-423B-9BD8-10C24A502BC2Q36952629-C9662B2D-BEF2-4A90-A7B4-9C6286A7080CQ36988417-A3B30436-9E79-4351-9920-5BFA17C4F9B0Q37188698-F581DC1F-AB8C-4A50-90AB-B9001946E1E7Q37255236-375FBAEA-14AF-4C10-8793-C8C6C82E3ECAQ37335690-5FFE2971-73EA-4F16-8987-A0EFA2DCFAC7Q37368214-49759FF6-94BC-4FF5-ADCC-463A7FE60B4AQ37371379-B2E8CB5B-DF81-46CE-AFC8-C89A1A920212Q37547130-F873E472-4DB7-40B2-AB9A-941B30C80AFCQ37588753-90B880AE-B170-4946-8AB0-BEBFBB4634D6Q37625058-9A3E3FEA-375A-42B1-9B37-786AF14DF1C2Q37930979-0CD41D03-7A2B-4C00-9668-4C591DEB1FFEQ38149853-C612BB01-F908-4ADF-A5E5-DB6A9AA85C59Q38368503-3BBC9218-2FDD-4F7D-BCC6-3708A9080985Q38613017-CA5B346E-BBB9-4250-A3A7-2561C36B9137Q38654271-6E4E78A2-A829-46C0-AED4-71DE0FC2A8B0Q38844782-C390CAA9-4AC3-4ED3-9C20-5F810029B915Q39017583-8DF6B34C-97AF-4FE8-8576-F0AF82080DE2Q39550704-B31BC1C0-2237-4839-947C-EEB59364187AQ41127869-0A92FCB9-E1A6-4136-98C1-689E7872753EQ41608422-1926EB2F-1439-4A8F-B3DA-717CAD51A494
P2860
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
High prevalence of the metabol ...... d cardiovascular risk factors.
@ast
High prevalence of the metabol ...... d cardiovascular risk factors.
@en
type
label
High prevalence of the metabol ...... d cardiovascular risk factors.
@ast
High prevalence of the metabol ...... d cardiovascular risk factors.
@en
prefLabel
High prevalence of the metabol ...... d cardiovascular risk factors.
@ast
High prevalence of the metabol ...... d cardiovascular risk factors.
@en
P2093
P2860
P356
P1476
High prevalence of the metabol ...... d cardiovascular risk factors.
@en
P2093
Annette Oeser
Ayumi Shintani
C Michael Stein
Cecilia P Chung
Ingrid Avalos
Paolo Raggi
P2860
P304
P356
10.1136/ARD.2006.054973
P407
P577
2006-08-10T00:00:00Z